0 ABC-family_proteins_mediated_transport 0.41 4.67 3.34 5 1.69 7.24 4.78 3.58 9.62 4.64 7.05 1.45 2.81 8.27 9.61 4.91 9.95 9.42 
1 ABCA_transporters_in_lipid_homeostasis 8.27 4.36 3.91 6.04 9.02 1.53 2.92 3.82 4.21 7.16 7.18 8.95 4.47 7.26 7.71 5.38 8.69 9.12 
2 Mitochondrial_ABC_transporters 6.67 2.99 0.35 8.94 7.03 8.11 3.22 3.33 6.73 6.64 1.41 7.11 2.53 8.68 5.47 6.44 6.62 7.57 
3 Apoptotic_execution__phase 0.37 8.59 7.23 7.41 5.29 7.78 3.16 0.35 1.9 8.42 2.88 1.06 0.4 9.42 2.64 6.48 4.46 8.05 
4 Extrinsic_Pathway_for_Apoptosis 8.9 7.29 3.7 3.5 0.06 1.01 3.93 5.48 6.29 6.23 0.84 9.54 7.56 8.4 9.66 3.76 9.31 3.08 
5 Intrinsic_Pathway_for_Apoptosis 9.44 4.39 6.26 3.23 5.37 5.38 1.18 0.82 9.29 5.41 8.33 1.15 6.39 6.58 7.04 9.3 9.77 3.06 
6 Regulation_of_Apoptosis 6.73 3.86 0.21 7.45 9.24 0.72 2.7 8.29 7.77 5.73 0.97 5.12 9.86 2.9 1.61 6.36 3.55 7.67 
7 Passive_Transport_by_Aquaporins 6.55 5.74 0.31 0.52 3.5 1.5 9.41 7.24 9.66 4.3 1.07 1.91 0.07 3.37 4.57 2.87 7.53 3.83 
8 Regulation_of_Water_Balance_by_Renal_Aquaporins 9.45 9.09 2.09 7.58 2.21 5.88 4.22 9.46 5.06 0.3 4.13 1.68 9 5.91 7.62 6.55 4.1 3.59 
9 Transport_of_Glycerol_from_Adipocytes_to_the_Liver_by_Aquaporins 6.24 5.37 5.48 4.83 5.95 0.41 6.02 3.5 2.91 8.36 3.74 0.2 5.96 0.21 3.48 1.99 6.68 4.84 
10 Scavenging_by_Class_A_Receptors 2.81 7.34 0.53 9.99 4.18 9.38 9 7.88 1.27 4.67 7.28 8.93 6.48 4.83 8.07 4.21 3.1 6.17 
11 Scavenging_by_Class_B_Receptors 8.13 5.14 3.09 6.16 9.35 4.51 6 2.49 5.19 5.56 7.98 3.03 2.24 0.08 8.44 6.09 9.89 7.02 
12 Scavenging_by_Class_F_Receptors 1.95 4.85 0.93 3.43 5.23 5.87 3.14 5.03 4.48 2 4.58 6.18 5.8 7.96 7.98 2.81 5.89 7.98 
13 Scavenging_by_Class_H_Receptors 0.09 1.57 4.72 6.22 5.38 2.92 0.38 1.79 1.9 6.57 9.58 1.91 8.15 8.88 1.56 5.11 2.02 6.34 
14 Scavenging_of_Heme_from_Plasma 2.72 0.55 3.28 6.46 3.62 8.86 8.75 4.33 8.69 1.42 8.44 4.16 8.81 9.98 3.22 6.51 0.21 6.99 
15 Cell_Cycle_Checkpoints 5.57 4.76 8.92 3.89 0.75 7.12 6 5.1 0.03 8.69 8.61 6.88 4.01 7.89 2.55 4.23 0.02 5.85 
16 Cell_Cycle,_Mitotic 1.82 2.85 0.88 4.26 6.17 7.57 8.32 9.32 1.69 1.54 7.21 1.89 9.76 3.29 3.68 6.92 4.25 5.55 
17 Chromosome_Maintenance 4.34 5.49 4.41 5.12 1.45 0.6 7.18 7.53 1.39 4.23 2.79 9.96 6.87 5.29 5.49 4.37 8.66 9.49 
18 Cell_junction_organization 1.93 1.95 2.97 4.16 2.86 1.05 4.88 2.82 4.55 7.34 1.14 7.01 3.16 6.71 7.86 2.63 3.13 3.55 
19 DSCAM_interactions 1.85 0.53 9.12 8.08 8.32 9.45 3.13 7.56 3.21 5.58 6.46 9.82 4.81 1.44 1.96 2.22 1.29 1.61 
20 Nephrin_interactions 5.35 4.5 1.73 4.66 0.44 6.59 2.92 4.39 2.53 0.24 1.54 5.1 7.45 6.49 1.86 3.13 4.74 0.22 
21 Signal_regulatory_protein_(SIRP)_family_interactions 1.68 0.18 7.87 9.05 9.58 3.91 2.02 6.25 4.77 4.14 3.14 8.24 3.34 8.74 3.72 1.59 8.33 0.7 
22 Cellular_Senescence 4.87 2.97 5.18 1.77 7.73 2.7 7.63 6.68 1.92 9.85 1.02 4.8 2.13 6.27 8.02 0.99 5.27 6.25 
23 Cellular_response_to_hypoxia 5.43 9.24 0.23 9.72 0.61 1.81 0.03 4.32 5.05 5.93 7.25 0.31 4.92 1.42 2.22 2.86 0.64 9 
24 Circadian_Clock 1.87 3.6 4.13 9.74 2.7 1.7 2.35 8.33 7.11 7.6 8.96 6.67 2.85 5.5 1.4 6.94 6.95 6.24 
25 BMAL1:CLOCK/NPAS2_Activates_Circadian_Expression 0.19 1.25 5.76 6.94 6.58 3.02 3.71 4.66 6.78 5.93 8.51 4.84 0.18 4.64 1.19 1.52 8 0.87 
26 Circadian_Repression_of_Expression_by_REV-ERBA 0.6 9.26 0.1 7.57 1.7 3.15 5.76 2.27 0.43 7.58 1.64 1.09 8.82 0.86 5.65 4.87 5.77 4.74 
27 RORA_Activates_Circadian_Expression 6.25 6.27 6.29 9.28 4.23 5.2 9.02 9.62 1.23 5.96 7.37 2.61 1.95 5.25 2.64 2.6 2.02 1.16 
28 Base_Excision_Repair 0.3 3.26 0.11 7.71 4.11 5.47 1.53 5.2 7.9 9.24 1.88 7.63 9.4 8.51 6.62 8.29 9 7.13 
29 DNA_Damage_Bypass 9.58 5.78 3.65 0.07 4.77 2 0.58 4.39 3.03 7.6 3.57 3.24 4.77 1.08 1.13 8.87 8.01 8.5 
30 DNA_Damage_Reversal 4.6 4.28 9.93 3.84 4.05 5.4 1.11 7.04 8.35 3.56 0.72 3.5 8.23 4.85 5.56 2.16 6.26 3.57 
31 Double-Strand_Break_Repair 5.26 3.57 3.37 2.71 8.69 3.61 8.96 0.22 6.17 1.12 7.17 6.96 5.85 0.41 4.23 1.29 2.29 5.65 
32 Fanconi_Anemia_pathway 5.59 9.32 2.96 8.55 0.53 9.62 5.84 7.34 6.54 9.72 4.57 3.69 5.32 9.63 6.07 4.83 9.11 6.35 
33 Nucleotide_Excision_Repair 0.67 8.48 6.75 9.38 2.23 1.42 7.54 5.11 7.41 1.75 4.59 8.25 2.21 8.7 6.26 9.34 2.05 7.83 
34 M/G1_Transition 8.5 3.98 2.79 7.01 1.93 7.34 6.37 5.34 5.56 9.93 1.76 7.05 9.62 5.48 8.81 3 4.13 6.41 
35 Regulation_of_DNA_replication 8.55 8.55 1.42 4.62 6.11 8.77 4.24 6.78 7.52 4.43 2.96 6.73 0.4 3.13 8.75 0.72 8.18 6.1 
36 Synthesis_of_DNA 0.17 9.32 1.12 6.95 1.69 8.31 0.4 4.88 6.85 0.9 4.97 5.89 9.9 1.45 3.53 3.14 6.51 7.4 
37 Axon_guidance 0.44 2.58 3.35 7.59 1.92 6.05 2.64 1.81 5.03 8.29 7.75 6.08 2.92 9.97 5.49 5.56 5.61 6.27 
38 Myogenesis 4.67 5.41 1.29 2.4 8.13 1.74 6.01 0.77 2.15 6.83 2.13 9.92 8.24 6.01 3.92 7.59 6.7 4.28 
39 Regulation_of_beta-cell_development 0.27 0.84 0.75 7.86 4.98 9.7 2.87 8.47 6.04 5.03 2.21 6.63 7.06 3.63 0.1 1.71 4.89 2.4 
40 Signaling_by_NODAL 1.64 5.42 6.19 9.13 5.91 7.04 8.18 2.32 7.5 2.05 9.75 5.39 3.03 4.22 0.98 2.47 5.84 6.48 
41 Transcriptional_Regulation_of_White_Adipocyte_Differentiation 9.71 8.64 9.13 0.75 5.45 7.12 5.46 6.78 7.69 2.62 5.19 9.85 2.89 9.44 8.65 5.4 2.45 5.08 
42 Abnormal_conversion_of_2-oxoglutarate_to_2-hydroxyglutarate 3.18 8.7 6.01 3.23 1.32 4.72 1.52 0.87 5.7 7.63 9.01 1.03 4.23 5.27 6 9.69 0.15 5.65 
43 Abnormal_metabolism_in_phenylketonuria 0.28 5.43 3.47 0.88 9.43 6.37 4.09 4.63 0.49 6.81 5.88 3.42 6.08 0.6 2.21 7.58 9.54 8.88 
44 Amyloids 1.46 6.9 9.49 8.43 4.3 6.2 7.48 0.67 5.36 7.83 0.35 2.26 1.85 0.38 8.53 6.29 2.24 7.48 
45 Botulinum_neurotoxicity 9.23 3.59 2.57 7.66 9.44 9.55 3.18 7.26 4.11 0.25 3.55 0.01 5.49 4.96 5.84 5.15 9.64 3.42 
46 Defects_in_vitamin_and_cofactor_metabolism 0.75 9.13 1.42 1.96 9.48 0.72 4.26 6.06 1.73 4.29 4.04 7.05 6.26 8.12 3.75 0.93 5.65 0.36 
47 Diseases_associated_with_visual_transduction 7.36 1.41 8.14 9.94 2.56 6.52 9.36 8.38 4.82 3.55 0.15 1.31 2.3 8.41 6.25 0.11 6.37 1.86 
48 HIV_Infection 6.9 6.5 6.62 6.34 8.93 3.53 4.16 4.52 0.08 2.62 2.33 4.54 3.03 6.34 3.03 2.56 1.48 1.24 
49 Influenza_Infection 3.17 2.13 1.09 0.28 2 0.8 3.18 8.58 0.5 1.55 3.61 2.64 9.03 6.76 6.43 9.09 9.02 5.61 
50 Latent_infection_of_Homo_sapiens_with_Mycobacterium_tuberculosis 4.89 9.48 2.82 6.53 6.74 2.2 4.02 9.23 8.31 3.69 8.78 2.59 0.08 6.19 9.71 0.03 9.45 7.81 
51 Mucopolysaccharidoses 5.04 3.92 6.85 3.13 6.98 5.89 7.22 9.38 0.37 4.1 4.61 2.34 5.08 9.61 9.59 4.93 5.15 2.69 
52 PI3K/AKT_Signaling_in_Cancer 9.37 8.69 0.58 7 9.71 2.64 1.17 2.15 5.55 8.15 3.3 0.39 2.12 2.88 0.82 9.54 0.85 7.1 
53 Signaling_by_EGFR_in_Cancer 4.84 7.74 3.8 8.15 9.51 5.41 1.15 6.79 1.1 8.98 0.73 7.88 9.77 1.32 9.56 6.89 1.13 0.08 
54 Signaling_by_FGFR_in_disease 9.41 7.9 7.23 3.63 0.28 1.84 7.78 2 0.71 8.85 9.74 0.71 3.33 8.67 1.53 2.95 1.68 8.25 
55 Signaling_by_NOTCH1_in_Cancer 6.76 6.29 6.5 5.98 3.09 6.93 6.86 0.8 1.16 2.49 6.67 5.28 6.79 8.64 4.21 4.05 8.26 8.16 
56 Signaling_by_TGF-beta_Receptor_Complex_in_Cancer 5.16 7.26 6.66 0.87 6.81 9.64 3.4 6.86 0.21 6.62 7.21 0.64 3.09 4.15 9.02 8.73 1.24 9.41 
57 Extracellular_matrix_organization 7.45 7.62 4.23 5.31 8.06 2.68 3.18 6.02 9.07 3.07 4.81 0.12 1.36 6.3 1.14 8.09 0.84 5.56 
58 Collagen_formation 2.9 2.93 9.96 1.52 0.54 3.45 7.08 2.48 4.91 7.12 1.31 1.14 4.39 9.58 7.22 7.04 9.95 0.52 
59 Degradation_of_the_extracellular_matrix 2.69 4.79 2.38 4.23 9.18 8.66 6.59 4.98 4.86 1.96 4.62 6.33 1.58 0.22 1.46 3.92 0.37 9.25 
60 ECM_proteoglycans 6.47 4.58 6.02 8.07 0.98 8.3 2.92 6 2.78 7.99 3.52 4.48 8.82 5.4 3.15 5.75 7.62 5.67 
61 Elastic_fibre_formation 3.36 3.97 4.18 8.97 8.28 8.51 8.16 2.3 4.49 9.25 6.58 2.29 5.2 9.4 5.6 1.47 1.62 6.55 
62 Fibronectin_matrix_formation 6.75 7.92 3.61 7.54 3.98 1.46 7.14 9.46 1.88 5.69 6.38 6.63 0.75 5.15 5.21 4.75 6.15 5.28 
63 Integrin_cell_surface_interactions 2.34 5.7 9.05 4.64 5.57 9.62 1.61 5.24 5.49 4.69 3.3 9.23 3.5 3.33 9.25 9.1 7.37 3.36 
64 Laminin_interactions 3.37 2.78 3.93 6.36 7.14 1.64 5.91 9.49 1.35 5.05 3.37 0.04 3.37 6.23 6.64 9.7 6.08 5.68 
65 Non-integrin_membrane-ECM_interactions 2.81 0.85 1.52 3.73 6.52 1.94 8.76 8.26 3.96 5.72 2.49 6.4 1.74 8.19 9.43 6.11 9.41 2.89 
66 Binding_of_RNA_by_Insulin-like_Growth_Factor-2_mRNA_Binding_Proteins_(IGF2BPs/IMPs/VICKZs) 4.19 5.65 8.05 5.85 2.16 4.5 6.15 6.09 0.64 1.66 8.93 0.74 5.09 3 6.95 5.73 5.89 1.61 
67 Deadenylation-dependent_mRNA_decay 1.72 9.68 3.58 0.31 2.68 4.26 5.1 4.22 7.74 7.79 9.1 5.52 1.82 3.91 4.95 7.64 8.74 3.64 
68 Generic_Transcription_Pathway 9.02 2.55 4.6 4.74 9.72 8.21 1.22 5.47 5.77 7.89 6.05 1.95 5.94 9.5 3.43 7.54 4.81 0.12 
69 Metabolism_of_non-coding_RNA 6.72 4.39 4.28 9.12 7.62 9.67 4.08 4.15 9.08 2.23 7.59 4.34 2.04 4.86 3.19 9.58 9.45 8.06 
70 Nonsense-Mediated_Decay 1.66 7 3.67 6.92 7.87 5.32 5.56 9.74 4.47 0.21 2.83 2.22 3.31 3.76 5.83 9.48 7.23 9.82 
71 Processing_of_Capped_Intron-Containing_Pre-mRNA 0.18 7.76 2.2 1.11 1.82 8.56 4.9 9.25 3.24 4.86 6.77 9.69 6.43 5.34 6.77 6.68 0.68 9.91 
72 Processing_of_Capped_Intronless_Pre-mRNA 1.96 7.83 8.28 7.27 4.26 8.71 6.97 6.12 7.03 0.27 4.08 5.45 5.08 1.85 2.38 2.37 4.43 3.13 
73 RNA_Polymerase_I,_RNA_Polymerase_III,_and_Mitochondrial_Transcription 5.01 8.5 1.28 1.11 6.5 1.49 1.92 4.54 8.69 6.81 4.65 2.67 7.13 7.93 6.34 4.72 9.72 8.3 
74 RNA_Polymerase_II_Transcription 9.01 4.42 1.77 8.77 7.7 7.02 3.64 3.81 5.9 8.23 2.37 0.23 1.79 5.95 1.69 3.27 0.42 3.1 
75 Regulation_of_mRNA_Stability_by_Proteins_that_Bind_AU-rich_Elements 1.82 0.58 9.26 4.87 6.7 5.28 6.51 2.58 2.13 8.6 7.83 2.86 7.42 6.1 4.72 1.28 4.34 8.41 
76 Regulatory_RNA_pathways 7.18 5.03 8.67 8.65 9.38 8.81 2.57 7.5 6.14 5.98 4.58 6.61 0.63 7.56 8.07 2.78 4.89 4.35 
77 Translation 3.65 0.75 5.86 3.86 8.33 3.6 3.3 0.48 9.28 4.92 4.33 8.4 7.66 7.35 8.1 5.99 8.37 8.92 
78 mRNA_Capping 9.82 3.28 3.52 3.69 2.44 7.94 6.08 2.52 6.47 4.32 5.35 2.08 2.64 4.97 2.43 6.49 0.15 8.41 
79 mRNA_Editing 1.89 1 8.12 6.48 5.23 8.51 4.74 6.33 8.91 2 8.54 9.9 6.97 9.19 7.8 5.78 9.31 5.44 
80 tRNA_Aminoacylation 3.4 4.87 8.99 5.25 4.83 5.38 4.92 1.93 2.52 0.11 5.6 8.34 8.4 4.97 7.85 5.29 5.4 8.05 
81 Cell_surface_interactions_at_the_vascular_wall 7.91 3.92 2.1 5.49 5.78 9.79 9.71 2.77 0.73 1.93 6.2 4.97 8.26 2.76 7.9 5.82 5.78 1.59 
82 Dissolution_of_Fibrin_Clot 4.18 4.89 1.59 4.49 9.24 0.72 3.8 0.08 9.67 2.08 4.77 5.03 3.7 6.07 1.96 0.74 7.22 6.11 
83 Factors_involved_in_megakaryocyte_development_and_platelet_production 0.19 7.61 0.56 8.9 1.63 6.83 7.16 9.32 4.52 7.41 9.54 8.13 8.62 3.96 4.6 6.15 9.04 5.99 
84 Formation_of_Fibrin_Clot_(Clotting_Cascade) 1.36 6.8 1.98 0.32 3.87 5.84 2.4 5.17 0.06 6.7 2.41 8.82 2.49 5.23 7.58 1.05 6.21 0.95 
85 Platelet_Adhesion_to_exposed_collagen 2.96 9.16 6.78 1.78 5.79 0.58 5.77 7.5 0.07 7.29 0.81 9.95 6.78 6.76 7.53 8.99 7.84 5.65 
86 Platelet_activation,_signaling_and_aggregation 0.93 6.08 1.72 2.43 9.29 5.14 1.68 0.55 1.91 9.73 9.22 7.48 6.51 9.86 1.44 4.46 5.77 5.17 
87 Platelet_homeostasis 6.29 9.16 8.74 7.91 4.69 9.12 1.46 6.93 0.91 8.15 9.49 8.57 6.4 0.52 2.36 5.51 4.87 2.26 
88 Adaptive_Immune_System 1.62 9.55 1.83 3.94 1.8 0.97 0.65 0.65 5.13 2.61 5.78 0.78 8.78 1.4 6.11 9.47 4.45 1.7 
89 Cytokine_Signaling_in_Immune_system 9.75 4.89 7.5 1.49 3.33 8.65 2.14 2.82 0.07 4.32 8.96 3.67 5.22 8.82 8.1 6.41 2.31 1.87 
90 Innate_Immune_System 7.05 4.79 3.21 5.38 3.51 4.47 2.08 6.46 2.76 7.59 1.89 4.22 6.66 4.86 4.55 0.28 6.14 8.6 
91 Ion_transport_by_P-type_ATPases 2.53 7.77 3.48 5.03 8.61 4.31 0.82 4.55 1.97 1.06 7.52 8.21 2.96 2.81 0.21 4.55 9.47 1.24 
92 Ligand-gated_ion_channel_transport 3.18 1.35 3.76 7.74 8.59 9.98 0.74 2.53 9.22 6.35 6.43 8.88 1.53 2.32 7.47 6.8 9.26 6.78 
93 Stimuli-sensing_channels 4.5 8.01 9.61 1.99 8.55 3.63 7.16 5.73 5.61 2.45 4.73 2.74 5.5 3.53 1.81 2.87 6.99 1.1 
94 Iron_uptake_and_transport 6.43 4.65 1.72 5.29 9.81 1.12 4.76 3.81 2.47 8.9 6.71 8.05 3.72 0.32 9.89 3.2 1.65 4.31 
95 Transferrin_endocytosis_and_recycling 6.58 2.93 2.06 5.78 9.48 2.06 1.71 1.66 3.96 6.97 0.2 6.94 5.29 7.88 1.09 9.84 9.69 9.78 
96 Meiotic_Recombination 6.17 0.15 6.26 6.84 1.68 9.06 9.28 0.97 1.18 3.9 1.99 7.85 4.86 1.99 4.2 7.1 2.71 8.13 
97 Meiotic_Synapsis 4.15 0.85 3.18 5.8 3.31 2.67 3.87 4.44 1.86 5.07 3.6 8.27 0.74 4.31 1.52 2.71 2.68 6.93 
98 ER_to_Golgi_Transport 8.85 3.37 3.11 6.04 6.77 4.06 7.68 0.22 4.13 0 5.42 5.37 0.38 3.88 3.55 2.89 6.47 1.81 
99 Endosomal_Sorting_Complex_Required_For_Transport_(ESCRT) 0.93 5.84 9.87 7.61 4.93 2.17 5.01 4.82 4.47 6.65 7.53 1.04 0.84 0.95 5.25 2.21 9.64 7.81 
100 Gap_junction_trafficking_and_regulation 8.72 1.06 6.56 3.43 5.93 0.8 0.8 8.68 4.11 7.13 9.68 2.51 2.16 0.79 7.68 0.4 5.31 9.33 
101 Golgi_to_ER_Retrograde_Transport 7.79 6.63 2.59 6.53 9.36 0.95 3.65 8.74 7.2 8.35 6.8 9.76 4.55 7.25 0.71 8.08 5.59 1.56 
102 Translocation_of_GLUT4_to_the_Plasma_Membrane 6.02 8.32 9.05 4.4 3.75 5.62 8.85 9.62 0.8 8.36 7.97 2.02 5.08 0.8 3.4 0.76 0.58 4.93 
103 trans-Golgi_Network_Vesicle_Budding 7.4 5.46 4.74 7.73 0.97 8.8 3.35 0.72 4 7.07 9.55 6.66 1.41 5.88 4.81 1.68 3.15 3.96 
104 Abacavir_transport_and_metabolism 2.25 0.09 0.12 1.36 4.55 7.62 0.43 7.42 0.21 9.22 5.12 2.48 0.18 3.68 7.17 7.14 6.5 2.9 
105 Biological_oxidations 3.35 7.59 1.69 8.95 3.03 6.4 9.79 1.99 1.05 7.91 6.61 6.81 6.52 7.53 0.33 0.29 9.87 0.42 
106 Cytosolic_Iron-sulfur_Cluster_Assembly 2.53 0.83 4.2 8.14 7.18 2.44 0.63 2.29 6.52 8.64 7.69 4.7 0.05 0.47 5.94 4.87 3.26 2.76 
107 Inositol_phosphate_metabolism 3.23 5.4 6.79 9.9 5.88 7.1 2.71 9.45 2.21 4.7 1.83 5.89 9.55 9.78 7.79 0.06 2.62 1.35 
108 Integration_of_energy_metabolism 4.87 1.96 0.33 0.88 9.35 7.79 9.93 7.9 9.62 9.65 0.01 1.05 8.07 5.67 6.69 1.34 6.71 4.57 
109 Metabolism_of_amino_acids_and_derivatives 9.98 5.45 5.97 2.18 8.38 8.44 3.72 5.63 0.28 2.64 8.01 7.23 4.9 6.04 6.01 2.27 1.97 6.92 
110 Metabolism_of_carbohydrates 7.71 3.63 3.01 3.63 7.21 5.65 4.21 4.45 6.1 4.95 7.41 0.22 8.12 1.51 0.15 0.55 3.93 7.38 
111 Metabolism_of_lipids_and_lipoproteins 2.79 8.82 6.08 6.54 8.22 7.07 2.45 3.38 1.44 2.9 3.39 1.54 6.04 6.23 2.25 0.78 7.24 9.81 
112 Metabolism_of_nitric_oxide 3.3 7.33 2.23 5.94 1.3 8.46 9.87 4.45 8.05 6.16 7.5 4.89 3.38 9.63 1.35 6.97 2.09 6.3 
113 Metabolism_of_nucleotides 2.24 9.08 7.37 4.74 9.2 3.72 2.93 8.55 7.34 5.61 0.56 6.06 1.84 0.75 3.82 1.19 7.41 4.32 
114 Metabolism_of_porphyrins 6.84 7.79 2.79 2.83 6.67 8.36 1.25 1.18 7.37 0.28 1.19 5.77 7.37 0.91 5.56 7.95 0.6 9.01 
115 Metabolism_of_vitamins_and_cofactors 7.93 4.32 1.36 5.8 8.75 9.07 1.84 0.74 7.19 7.9 4.76 0.41 3.51 3.29 2.9 9.74 0.72 5.91 
116 Mitochondrial_Iron-Sulfur_Cluster_Biogenesis 1.89 7.87 4.9 2.39 8.93 0.53 0.63 6.81 9.03 0.05 1.76 4.79 6.95 1.39 4.68 9.98 0.83 6.39 
117 O2/CO2_exchange_in_erythrocytes 5.15 6.21 9.93 8.26 7.22 8.38 8.28 5.81 3.99 9.78 8.91 0.23 9.43 8.34 2.43 3.49 7.02 7.07 
118 Reversible_Hydration_of_Carbon_Dioxide 5.02 1.41 6.87 3.46 8.91 6.37 4.13 4 8.16 6.9 1.62 9.35 1.26 4.1 8.77 3.82 2.6 1.89 
119 The_citric_acid_(TCA)_cycle_and_respiratory_electron_transport 7.05 8.74 6.63 7.22 1.95 5.66 3.6 0.38 5.88 8.11 2.45 4.67 4.25 8.67 1.89 5.42 0.63 5.47 
120 Mitochondrial_Protein_Import 5.02 6.17 0.99 0.23 2.26 2.03 0.48 0.51 5.7 6.36 4.58 9.67 4.56 4.05 5.31 9.62 8.19 9.75 
121 Peptide_hormone_metabolism 5.56 5.31 4.95 0.44 5.91 8.03 3.88 9.15 4.5 3.19 2.72 7.91 3.83 1.33 7.75 6.42 5.69 3 
122 Post-translational_protein_modification 9.54 0.78 5.85 2.57 3.33 8.93 4.9 1.03 7.5 2.33 7.22 2.71 6.11 9.9 3.38 6.41 2.58 0.47 
123 Protein_folding 3.52 6.58 4.79 3.02 6.83 9.9 0.02 5.68 4.22 8.95 1.35 0.08 3.61 7.42 1.94 6.99 1.88 1.78 
124 Regulation_of_Insulin-like_Growth_Factor_(IGF)_Transport_and_Uptake_by_Insulin-like_Growth_Factor_Binding_Proteins_(IGFBPs) 0.42 3.57 9.41 8.47 4.69 3.45 3.8 9.13 9.64 7.1 0.61 3.85 0.73 5.04 4.62 7.03 1.02 0.69 
125 Translation 1.54 5.29 5.52 0.74 1.49 7.3 2.44 8.44 0.49 1.18 0.65 3.63 5.52 7.73 4.7 7.31 7.47 5.11 
126 Unfolded_Protein_Response 8.69 3.98 4.98 1.03 3.52 6.79 0.53 0.43 5.22 0.88 5.63 8.34 8.5 0.22 2.4 9.11 4.92 6.51 
127 Smooth_Muscle_Contraction 5.8 4.77 6.16 8.76 1.78 2.2 6.15 3.48 7.98 1.79 6.35 8.57 8.83 6.62 9.02 2.62 4.2 7.7 
128 Striated_Muscle_Contraction 0.22 2.73 8.41 6.86 8.88 9.17 7.17 8.92 6.98 2.67 7.49 0.65 3.89 9.32 6.19 0.81 0.03 1.3 
129 Botulinum_neurotoxicity 0.28 6.31 5.89 1.52 6.3 1.72 8.64 4.07 2.95 4.28 6.81 4.9 6.1 1.77 0.71 2.36 4.59 6.43 
130 Potassium_Channels 8.4 6.33 0.37 8.93 6.3 2.74 9.93 7.82 2.03 4.61 2.9 6.62 3.07 9.97 1.51 4.23 8.9 7.17 
131 Transmission_across_Chemical_Synapses 6.4 7.03 5.66 8.83 6.61 6.59 2.45 3.86 6.51 7.65 6.01 8.4 2.09 4.97 2.83 2.5 0.58 4.21 
132 Transmission_across_Electrical_Synapses_ 1.75 5.81 7.87 2.71 2.87 9.99 5.04 9.79 1.38 7 5.3 4.61 1.18 2.05 5.4 8.28 4.59 6.22 
133 Conjugation_of_SUMO_to_E1_(UBA2:SAE1) 3.98 7.6 0.98 9.35 4.81 6.14 5.67 4.93 5.96 1.61 7.46 5.38 6.7 5.38 4.76 5.55 9.17 3.71 
134 Proteolytic_Processing_of_SUMO 7.6 7.52 7.58 4.33 2.55 0.65 7.26 4.01 0.34 7.59 3.93 5.48 2.73 7.92 1.93 9.33 1.37 1.03 
135 Transfer_of_SUMO_from_E1_to_E2_(UBE2I,_UBC9) 6.9 2.11 6.94 6.68 6.27 4.98 9.89 2.48 8.79 6.47 1.49 9.31 6.69 8.75 5.98 4.49 4.36 5.99 
136 Fertilization 1.23 4.43 7.31 1.54 8.61 4.34 3.85 9.67 8.16 3.93 7.04 8.66 9.53 3.08 2.23 6.84 7.92 6.67 
137 Hexose_transport 0.48 4.69 9.3 8.11 8.14 0.9 4.27 7.43 6.04 5.99 4.74 1.95 5.06 1.58 5.89 8.58 8.09 8.89 
138 Transport_of_glucose_and_other_sugars,_bile_salts_and_organic_acids,_metal_ions_and_amine_compounds 4.47 0.4 8.18 3.64 9.75 0.26 0.89 5.03 0.66 4.12 8.4 5.7 6.76 3.95 6.41 9.86 6.51 1.09 
139 Transport_of_inorganic_cations/anions_and_amino_acids/oligopeptides 1.87 0.83 0.85 3.9 2.5 6.86 7.55 3.81 1.28 5.02 2.77 8.62 4.24 5.65 8.72 8.32 8.85 4.28 
140 Transport_of_vitamins,_nucleosides,_and_related_molecules 6.46 8.89 4.78 8.83 9.25 2.65 2.6 0.45 7.78 8.21 8.55 5.2 9.27 7.73 1.34 2.51 6.75 3.36 
141 Processing_and_Activation_of_SUMO 3.34 0.01 7.37 3.1 9.74 5.9 3.56 0.71 0.8 9.35 1.45 2.82 8.25 7.18 5.73 7.12 0.37 9.98 
142 DAG_and_IP3_signaling 9.05 1.62 7.17 6.92 5.39 0.47 9.46 1.03 2.31 1.15 8.39 8.58 8.29 6.45 3.94 1.99 6.45 2.72 
143 Integrin_alphaIIb_beta3_signaling 6.75 8.62 0.72 7.73 4.8 2.38 8.97 5.42 6.08 2.03 2.77 1.25 1.34 4.01 0.78 3.82 1.69 7.36 
144 PIP3_activates_AKT_signaling 4.78 9.39 1.38 7.21 4.26 6.63 6.77 5.75 7.24 9.81 7 9.61 8.62 0.02 4.48 0.95 6.84 0.16 
145 RAF/MAP_kinase_cascade 1.37 5.07 9.93 2.84 9.44 2.59 8.21 0.58 6.43 6.68 6.77 1.19 8.57 0.41 8.91 2.64 6.23 9.15 
146 Signaling_by_Activin 0.72 9.29 8.41 7.15 6.15 5.36 9.57 7.59 7 4.52 0.93 2.41 8.29 4.48 2.27 7.98 2.24 3.24 
147 Signaling_by_BMP 2.74 1.33 8.85 0.38 1.7 8.62 6.29 0.84 9.09 8.78 9.23 0.85 4 0.24 1.93 1.05 4.12 7.65 
148 Signaling_by_EGFR 7.67 4.07 6.77 7.84 7.04 7.9 8.34 8.91 6.21 0.85 7.34 1.9 5.42 9.98 0.86 0.18 6.21 4.24 
149 Signaling_by_ERBB2 5.97 3.76 2.54 6.69 1.08 9.27 4.93 0.68 3.66 1.02 4.38 6 8.19 3.18 2.9 9.84 3.39 5.56 
150 Signaling_by_ERBB4 8.08 6.32 4.78 8.14 7.87 2.39 0.74 0.2 8.27 5.54 9.88 4.41 7.98 6.42 0.02 3.21 1.04 9.46 
151 Signaling_by_FGFR 0.56 5.09 8.33 7.08 7.61 5.33 6.86 8.04 3.85 1.42 8.42 2.6 1.61 6.2 3.43 5.78 1.87 1.13 
152 Signaling_by_GPCR 0.63 5.91 9.34 4.15 6.56 7.61 0.12 4.11 9.59 2.51 7.38 3.7 1.24 5.07 0.07 5.84 9.51 1.01 
153 Signaling_by_Hippo 4.89 9.58 4.41 7.9 0.13 4.12 8.55 0.6 0.93 4.72 4.02 6.76 5.43 3.73 2.66 6.51 2.75 5.28 
154 Signaling_by_Insulin_receptor 5.32 7.61 4.69 5.03 7.29 1.07 8.92 4.51 9.53 3.92 5.7 5.19 4.72 4.07 4.94 5.05 4.4 3.83 
155 Signaling_by_Leptin 2.62 4.09 6.07 0.38 3.6 4.71 1.71 6.54 9.47 5.14 5.23 2.29 4.89 7.66 8.87 7.56 6.32 4.7 
156 Signaling_by_NOTCH 7.39 6.66 5.22 2.83 1.6 5.53 7.05 0.91 2.59 3.86 6.87 6.29 0.42 3.17 0.45 3.56 3.88 4.52 
157 Signaling_by_PDGF 1.54 4.66 8.33 7.6 9.19 6.31 7.38 2.67 7.76 0.98 3.14 3.2 0.53 0.07 4.69 2.16 7.22 8.42 
158 Signaling_by_Rho_GTPases 0.07 4.63 2.6 9.47 7.93 6.3 7.17 0.43 3.76 3.14 6.26 1.17 3.34 6.2 1.71 7.92 9.64 1.54 
159 Signaling_by_SCF-KIT 8.66 6.93 6.64 7.75 0 2.12 1 5.51 4.76 3.79 9.43 8.77 7.89 3.61 3.85 2.72 4.34 1.44 
160 Signaling_by_TGF-beta_Receptor_Complex 5.61 5.63 5.04 9.46 8.88 3.08 1.57 4.3 1.23 4.64 0.74 3.46 8.37 9.81 3.18 6.11 2.92 5.91 
161 Signaling_by_Type_1_Insulin-like_Growth_Factor_1_Receptor_(IGF1R) 8.32 1.23 4.61 9.91 4.61 3.3 4.98 3.69 2.91 4 1.79 1.17 3.17 9.14 5.95 4.41 9.36 8.67 
162 Signaling_by_VEGF 0.28 4.53 9.09 9.73 9.81 5.03 5.69 8.16 8.83 3.67 3.85 4.02 2.3 1.57 6.81 5.67 3.1 8.66 
163 Signaling_by_Wnt 6.87 1.71 4.77 2.45 7.64 2.38 6.71 0.47 1.15 5.92 3.11 6.57 4.05 0.53 1.71 5.8 7.4 5.3 
164 Signalling_by_NGF 6.75 3.2 7.9 3.77 9.98 5.86 6.04 4.89 6.31 7.44 3.88 6.1 7.18 9.19 2.59 9.27 6.09 1.19 
165 Visual_phototransduction 4.79 7.16 3 3.96 8.53 4.58 8.3 5.93 8.06 8.49 8.54 2.72 1.6 2.94 0.54 3.33 1.46 2.29 
166 ABC-family_proteins_mediated_transport 4.71 4.28 5.59 2.41 4.21 6.88 3.66 0.33 6.85 2.7 3.29 2.61 8.6 2.08 9.82 1.62 5.06 8.78 
167 Aquaporin-mediated_transport 9.79 8.97 8.87 5.38 4.69 7.83 5.4 7.95 2.66 6.33 5.09 5.57 3.17 1.34 0.53 1.35 2.58 5.93 
168 Ion_channel_transport 8.43 6.93 4.66 9.51 1.4 0.94 9.37 1.74 5.12 0.97 5.51 6.95 8.17 4.92 2.92 2.37 5.3 6.13 
169 Iron_uptake_and_transport 2.96 7.1 3.89 6.28 8.09 7.86 7.44 8.4 1.82 5.69 1.2 3.93 2.92 9.62 2.14 5.27 8.07 1.94 
170 SLC-mediated_transmembrane_transport 7.05 7.13 0.11 9.13 6.93 6.64 2.03 9.95 7.62 3.81 9.46 9.09 0.48 7.68 6.24 5.11 9.54 2.35 
